Open access

COVID-19 vaccines in the WHO's Emergency Use Listing (EUL) Report (5) - 30.09.2021

MandatorSwiss Federal Office of Public Health (FOPH)
Number of pages63
PublisherBern : Swiss School of Public Health plus (SSPH+)
  • COVID-19 vaccines in the WHO's Emergency Use Listing (EUL) Report; 5
Publication date2021-09-30
First online date2021-09-30

This report focuses on the World Health Organization's (WHO) Emergency Use Listing (EUL) of authorized vaccines as of 30 September 2021. Currently six vaccines are authorised for emergency use: BNT162b2/COMIRNATY (Pfizer-BioNTech, USA), Spikevax/Moderna COVID-19 Vaccine/ mRNA-1273 (Moderna, USA), Vaxzevria/ChAdOx1 nCoV-19/AZD1222/Covishield (AstraZeneca/Oxford, UK, India), Janssen Covid-19 vaccine/Johnson & Johnson (Janssen, USA), Sinopharm/BBIBP-CorV (China), and Sinovac/CoronaVac (China). This report provides a condensed summary concerning vaccine efficacy, safety, protection against variants, and further important information for each vaccine, in the form of a synoptic table. The information and data in this synoptic table was extracted from phase III clinical trials and from observational studies. This report particularly focuses on the latest data on vaccine effectiveness, updates on the Janssen COVID-19 vaccine, booster doses, and new data on the safety and immunogenicity of the Sinopharm and Pfizer and BioNtech vaccine in children.

Citation (ISO format)
RODRIGUEZ VELÁSQUEZ, Sabina et al. COVID-19 vaccines in the WHO’s Emergency Use Listing (EUL) Report (5) - 30.09.2021. 2021
Main files (1)
  • PID : unige:157777

Technical informations

Creation10/13/2021 3:47:00 PM
First validation10/13/2021 3:47:00 PM
Update time03/16/2023 2:18:48 AM
Status update03/16/2023 2:18:47 AM
Last indexation01/29/2024 11:15:02 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack